No Data
No Data
Moderna in Joint Deal to Commercialize Covid-19 Vaccine in Japan
By Sabela Ojea Moderna has signed a deal with Japan-based Mitsubishi Tanabe Pharma to handle the manufacturing, sales and distribution of its Covid-19 Spikevax vaccine and other mRNA respiratory vacci
Express News | Moderna :Co & Mitsubishi Tanabe Pharma Enter Joint Agreement to Promote Co’s Mrna Respiratory Vaccine Portfolio in Japan, Including Covid-19 Vaccines
Unpacking the Latest Options Trading Trends in Moderna
Investors with a lot of money to spend have taken a bullish stance on Moderna (NASDAQ:MRNA).And retail traders should know.We noticed this today when the trades showed up on publicly available options
AI Has 'The Hallmarks Of An Inflating Bubble,' Warns Veteran Wall Street Investor
Signs are emerging that the market boom surrounding artificial intelligence (AI) might be taking on the characteristics of a bubble.
Here's How Much $1000 Invested In Moderna 5 Years Ago Would Be Worth Today
Moderna (NASDAQ:MRNA) has outperformed the market over the past 5 years by 37.68% on an annualized basis producing an average annual return of 50.84%. Currently, Moderna has a market capitalization of
Moderna Given $176 Million to Advance Bird Flu Vaccine